QUANTITATIVE MYOCARDIAL BLOOD FLOW AS A PROGNOSTIC MARKER FOR CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A MULTICENTRE STUDY

被引：0
|
作者：
Sharrack, Noor [1 ]
Knott, Kristopher [2 ]
Yeo, Jian L. [3 ]
Kotecha, Tushar [4 ]
Brown, Louise [1 ]
Porcari, Aldostefano [4 ]
Gulsin, Gaurav S. [3 ]
Thirunavukarasu, Sharmaine [1 ]
Chowdhary, Amrit [1 ]
Levelt, Eylem [1 ]
Moon, James [5 ]
McCann, Gerry [3 ]
Fontana, Marianna [4 ]
Kellman, Peter [6 ]
Munyombwe, Theresa [7 ]
Greenwood, John P. [1 ]
Swoboda, Peter [1 ]
Plein, Sven [1 ]
机构：
[1] Leeds Inst Cardiovasc & Metab Med, 6 Clarendon Way, Leeds LS2 9DA, LDS, England
[2] St George Hosp, London, England
[3] Univ Leicester, Leicester, Leics, England
[4] Royal Free Hosp, London, England
[5] Barts Heart Ctr, London, England
[6] NIH, Bldg 10, Bethesda, MD 20892 USA
[7] Univ Leeds, Leeds, W Yorkshire, England
来源：
HEART | 2022年 / 108卷
关键词：
D O I：
10.1136/heartjnl-2022-BCS.138
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
138
引用
收藏
页码：A104 / A105
页数：2
相关论文
共 50 条
  • [1] Quantitative myocardial blood flow as a prognostic marker for cardiovascular outcomes in patients with Type 2 Diabetes Mellitus: a multicentre study
    Sharrack, N.
    Knott, K. D.
    Yeo, J. L.
    Kotecha, T.
    Brown, L. A. E.
    Thirunavukarasu, S.
    Chowdhary, A.
    Levelt, E.
    Moon, J. C.
    McCann, G. P.
    Fontana, M.
    Kellman, P.
    Munyombwe, T.
    Swoboda, P.
    Plein, S.
    EUROPEAN HEART JOURNAL, 2022, 43 : 284 - 284
  • [2] Cardiovascular outcomes in patients with Type 2 diabetes mellitus after the first acute myocardial infarction
    Mozejko-Pastewka, B
    Taton, J
    Kinalska, I
    Gorska, M
    Grzywa, M
    Gromniak, E
    Gromniak, E
    Haczynski, J
    Milicevic, Z
    DIABETOLOGIA, 2003, 46 : A361 - A362
  • [3] Osteprotegerin as cardiovascular risk marker in patients with type 2 diabetes mellitus
    Rozas-Moreno, P.
    Munoz-Torres, M.
    Alonso, G.
    Fernandez-Garcia, D.
    Luque-Fernandez, I.
    Sebastian-Ochoa, A.
    Escobar-Jimenez, F.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S271 - S271
  • [4] Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
    Scirica, Benjamin M.
    Bhatt, Deepak L.
    Braunwald, Eugene
    Steg, P. Gabriel
    Davidson, Jaime
    Hirshberg, Boaz
    Ohman, Peter
    Frederich, Robert
    Wiviott, Stephen D.
    Hoffman, Elaine B.
    Cavender, Matthew A.
    Udell, Jacob A.
    Desai, Nihar R.
    Mosenzon, Ofri
    McGuire, Darren K.
    Ray, Kausik K.
    Leiter, Lawrence A.
    Raz, Itamar
    Braunwald, Eugene
    Bhatt, Deepak L.
    Scirica, Benjamin M.
    Udell, Jacob A.
    Cavender, Matthew A.
    Desai, Nihar
    Abrahamsen, Timothy
    Grossman, Michelle
    Morin, Suzanne
    Im, Kyungah
    Hoffman, Elaine
    Gabovitch, Daniel
    Pricken, Alexandra
    Mosenzon, Ofri
    Buskila, Alona
    Ohman, Peter
    Hirshberg, Boaz
    Stahre, Christina
    Price, Deborah
    Billing-Clason, Solveig
    Sabel, Karin
    Monyak, John
    Sjostrand, Mikalea
    Wei, Cheryl
    Lu, Jane
    Miller, Elinor
    Raichlen, Joel
    Fitt, Sandy
    Frederich, Robert
    Iqbal, Nayyar
    Donovan, Mark
    Davidson, Jaime A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14): : 1317 - 1326
  • [5] Myocardial Blood Flow in Angiographically Normal Patients with Type 2 Diabetes Mellitus, Prediabetes and Normal Controls - A Cardiovascular Magnetic Resonance Perfusion Study
    Larghat, Abdulghani M.
    Biglands, John
    Greenwood, John P.
    Fairbairn, Timothy A.
    Maredia, Neil
    Radjenovic, Aleksandra
    Ball, Stephen G.
    Plein, Sven
    CIRCULATION, 2011, 124 (21)
  • [6] Expression of miRNAs as a marker for cardiovascular risk in patients with type 2 diabetes mellitus
    Gateva, P.
    Mihaleva, I.
    Kamenova, K.
    Giragosyan, S.
    Dodova, R.
    Kaneva, R.
    Dimova, I.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 852 - 853
  • [7] Risk Factors and cardiovascular Outcomes in Patients with type 2 Diabetes Mellitus
    Pavlicek, Vojtech
    DIABETOLOGE, 2018, 14 (07): : 499 - 500
  • [8] Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
    Inzucchi, Silvio E.
    Wanner, Christoph
    Lachin, John M.
    Fitchett, David
    Bluhmki, Erich
    Hantel, Stefan
    Mattheus, Michaela
    Devins, Theresa
    Johansen, Odd Erik
    Woerle, Hans Juergen
    Broedl, Uli C.
    Zinman, Bernard
    CIRCULATION, 2015, 132 (23) : 2271 - 2271
  • [9] Incremental Value of Abnormal Quantitative Myocardial Perfusion and Myocardial Infarction Using Cardiovascular Magnetic Resonance as Prognostic Markers in Type 2 Diabetes Mellitus
    Sharrack, Noor
    Knott, Kristopher D.
    Yeo, Jian L.
    Kotecha, Tushar
    Brown, Louise A.
    Porcari, Aldostefano
    Adam, Robert D.
    Gulsin, Gaurav
    Thirunavukarasu, Sharmaine
    Chowdhary, Amrit
    Levelt, Eylem
    Moon, James
    McCann, Gerry
    Fontana, Marianna
    Kellman, Peter
    Munyombwe, Theresa
    Gale, Chris P.
    Buckley, David L.
    Swoboda, Peter P.
    Greenwood, John
    Plein, Sven
    CIRCULATION, 2023, 148
  • [10] Retrospective analysis of cardiovascular outcomes in patients with type 2 diabetes mellitus after the first acute myocardial infarction
    Mozejko-Pastewka, B
    Taton, J
    Haczynski, J
    Strojek, K
    Ametov, AS
    Milicevic, Z
    ACTA DIABETOLOGICA, 2003, 40 (Suppl 2) : S354 - S357
12345